SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001493152-24-036454
Filing Date
2024-09-16
Accepted
2024-09-16 17:30:30
Documents
3

Document Format Files

Seq Description Document Type Size
1 form424b5.htm 424B5 493615
2 form424b5_001.jpg GRAPHIC 4544
3 form424b3_001.jpg GRAPHIC 4605
  Complete submission text file 0001493152-24-036454.txt   507569
Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Filer) CIK: 0001859007 (see all company filings)

IRS No.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-281914 | Film No.: 241302039
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)